Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, if he will publish (a) the minutes from and (b) a list of attendees at the workshops his Department has been running ahead of negotiations on a new Voluntary Scheme for Branded Medicines Pricing and Access.
The objective of the pre-negotiation workshops was to enable a mutual understanding of the impact of the current voluntary scheme upon the different organisations represented, and to discuss the potential objectives and priorities for a new voluntary scheme. The discussions in the workshops will feed into the upcoming negotiation of a successor to the 2019 voluntary scheme for branded medicines pricing and access. In order to facilitate a transparent and candid discussion, participants agreed that all contributions would be kept confidential to those who attended.
The following external organisations were invited to the workshops:
Industry bodies:
- Association of the British Pharmaceutical Industry
- British Generic Manufacturers Association
- Ethical Medicines Industry Group
- BioIndustry Association
Patient organisations and civil society organisations:
- Cancer52
- The Blood Cancer Alliance
- The Charity Medicines Access Coalition
- National Voices
- The Patients Association
- Alzheimer’s Research UK
- Anthony Nolan
- Cystic Fibrosis Trust
- Genetic Alliance UK
- The Association of Medical Research Charities
- Breast Cancer Now
- Myeloma UK
- Office of Health Economics
- King’s Fund
- NHS Confederation